Company: CRVO
Filing Date: 2025-03-17
Form Type: S-8
Source: 0001437749-25-007840
Chunk: 7

Company: CervoMed Inc.
Filing Date: 2025-03-17
Form: S-8
Chunk 7
---
 of this Registration Statement).                                                     |     |                 |     |           |     |            |     | X              |
| 99.1

#          |     | CervoMed Inc. 2015 Equity Incentive Plan.                                                                                              |     | DEF 14A         |     | 6/10/2016 |     | Appendix C |     |                |
| 99.2

#          |     | Amendment No. 1 to CervoMed Inc. 2015 Equity Incentive Plan.                                                                           |     | DEF 14A         |     | 6/10/2016 |     | Appendix B |     |                |
| 99.3

#          |     | Form of Stock Option Award Agreement under 2015 Equity Incentive Plan.                                                                 |     | 10-K            |     | 3/17/2021 |     |       10.7 |     |                |
| 99.4

#          |     | Form of Inducement Non-Qualified Stock Option Agreement.                                                                               |     | 10-K            |     | 3/17/2025 |     |      10.10 |     |                |
| 107            |     | Calculation of Filing Fee Table.                                                                                                       |     |                 |     |           |     |            |     | X              |

# Indicates management contract or compensatory plan.
Item 9. Undertakings.

| 1. | The Registrant hereby undertakes: |

| (a) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |

| (i) | To include any prospectus required by Section 10(a)(3) of the Securities Act; |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent